Related Experiment Video
Updated: Oct 22, 2025

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
Published on: August 20, 2019
Primary hypercholesterolemia and development of cardiovascular disorders: Cellular and molecular mechanisms involved
Aida Collado1, Elena Domingo1, Laura Piqueras2
1Department of Pharmacology, Faculty of Medicine, University of Valencia, Valencia, Spain; Institute of Health Research INCLIVA, University Clinic Hospital of Valencia, Valencia, Spain.
Insights
Primary hypercholesterolemia, marked by high LDL cholesterol, drives atherosclerosis. Understanding its inflammation and endothelial dysfunction mechanisms can reveal new cardiovascular disease treatments.
Area of Science:
- Biochemistry
- Immunology
- Cardiovascular Medicine
Background:
- Primary hypercholesterolemia involves elevated low-density lipoproteins (LDL), a key factor in arteriosclerosis.
- Atherosclerosis underlies most cardiovascular diseases, including myocardial infarction and stroke.
- Low-grade systemic inflammation and endothelial dysfunction are primary drivers of premature atherosclerosis.
Purpose of the Study:
- To review cellular and molecular mechanisms of inflammation and endothelial dysfunction in primary hypercholesterolemia.
- To explore the role of inflammatory mediators, immune cells, and signaling pathways in atherogenesis.
- To identify potential therapeutic targets for cardiovascular disease progression.
Main Methods:
- Literature review of current scientific knowledge.
- Analysis of cellular and molecular mechanisms.
- Discussion of inflammatory mediators and signaling pathways.
Main Results:
- Elevated LDL cholesterol contributes to arteriosclerosis.
- Systemic inflammation and endothelial dysfunction are critical in atherosclerosis development.
- Leukocyte adhesion to dysfunctional endothelium is a key feature of atherogenesis.
Conclusions:
- Understanding hypercholesterolemia-linked inflammation and dysfunction is crucial for cardiovascular disease insights.
- This knowledge may lead to novel therapeutic strategies to slow disease progression.
Abstract:
Primary hypercholesterolemia, a metabolic disorder characterized by elevated circulating levels of cholesterol products, mainly low-density lipoproteins, is associated with arteriosclerosis development. Cardiovascular disease, predominantly myocardial infarction and stroke, remains the main cause of death worldwide, with atherosclerosis considered to be the most common underlying pathology. In addition to elevated plasma levels of low-density lipoproteins, low-grade systemic inflammation and endothelial dysfunction seem to be the main drivers of premature atherosclerosis. Here we review current knowledge related to cellular and molecular mechanisms involved in low-grade systemic inflammation and endothelial dysfunction associated with primary hypercholesterolemia. We also discuss the contribution of different inflammatory mediators, immune players and signaling pathways implicated in leukocyte adhesion to the dysfunctional endothelium, a key feature of atherogenesis development. A better understanding of these processes linked to primary hypercholesterolemia should shed new light on cardiovascular disease development and might guide novel and effective therapeutic strategies to impair its progression.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Inflammation
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction

